Suppression of cytophilic antibody ('arming' factor) in the sera of patients with prostatic cancer by human seminal plasma

R. A. Bhatti, R. J. Ablin, S. Zamora, E. Totonchi, I. M. Bush, P. D. Guinan

Research output: Contribution to journalArticlepeer-review

Abstract

The 'arming' of normal peripheral blood leukocytes (PBL) by cytophilic antibody in the sera of prostatic cancer patients is suppressed by pretreatment of PBL with normal human seminal plasma (HuSP1). Suppression of cytophilic antibody by HuSP1 extends the spectrum of immunologic reactions on which SP1 has an immunosuppressive effect and may provide further insight into the possible role of SP1 in the natural history of prostatic cancer.

Original languageEnglish (US)
Pages (from-to)349-350
Number of pages2
JournalExperientia
Volume36
Issue number3
DOIs
StatePublished - Mar 1980
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint

Dive into the research topics of 'Suppression of cytophilic antibody ('arming' factor) in the sera of patients with prostatic cancer by human seminal plasma'. Together they form a unique fingerprint.

Cite this